60Meaning of residential medication management review in item 903

60 Meaning of residential medication management review in item 903 (1) For item 903, a residential medication management review is a collaborative service provided by a medical practitioner and a pharmacist to review the medication management needs of a permanent resident of a residential aged care facility. (2) A medical practitioner’s involvement in a residential medication management review includes all of the following: (a) discussing the proposed review with the resident and seeking the resident’s consent to the review; (b) collaborating with the reviewing pharmacist about the pharmacist’s involvement in the review; (c) providing input from the resident’s most recent comprehensive medical assessment or, if such an assessment has not been undertaken, providing relevant clinical information for the review and for the resident’s records; (d) subject to subrule (4), participating in a post‑review discussion (either face‑to‑face or by telephone) with the pharmacist to discuss the outcomes of the review including: (i) the findings of the review; and (ii) medication management strategies; and (iii) means to ensure that the strategies are implemented and reviewed, including any issues for implementation and follow‑up; (e) developing or revising the resident’s medication management plan after discussion with the reviewing pharmacist, and finalising the plan after discussion with the resident. (3) A medical practitioner’s involvement in a residential medication management review also includes: (a) offering a copy of the medication management plan to the resident (or the resident’s carer or representative if appropriate); and (b) providing copies of the plan for the resident’s records and for the nursing staff of the residential aged care facility; and (c) discussing the plan with nursing staff if necessary. (4) A post‑review discussion is not required if: (a) there are no recommended changes to the resident’s medication management arising out of the review; or (b) any changes are minor in nature and do not require immediate discussion; or (c) the pharmacist and medical practitioner agree that issues arising out of the review should be considered in an enhanced primary care case conference.